Jane Street Group LLC grew its holdings in shares of TruBridge, Inc. (NASDAQ:TBRG - Free Report) by 211.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 104,331 shares of the company's stock after acquiring an additional 70,850 shares during the quarter. Jane Street Group LLC owned 0.70% of TruBridge worth $2,057,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of TBRG. Tower Research Capital LLC TRC raised its stake in TruBridge by 47.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,170 shares of the company's stock worth $43,000 after acquiring an additional 699 shares in the last quarter. Covestor Ltd raised its stake in TruBridge by 20.5% during the fourth quarter. Covestor Ltd now owns 2,819 shares of the company's stock worth $56,000 after acquiring an additional 479 shares in the last quarter. AlphaQuest LLC bought a new stake in shares of TruBridge during the fourth quarter worth about $66,000. EMC Capital Management grew its holdings in shares of TruBridge by 2,704.0% during the fourth quarter. EMC Capital Management now owns 5,608 shares of the company's stock worth $111,000 after purchasing an additional 5,408 shares during the last quarter. Finally, Barclays PLC bought a new stake in shares of TruBridge during the third quarter worth about $150,000. Institutional investors and hedge funds own 88.64% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the company. Cantor Fitzgerald boosted their price target on TruBridge from $20.00 to $29.00 and gave the stock an "overweight" rating in a report on Tuesday, March 11th. Stephens restated an "equal weight" rating and set a $28.00 price target on shares of TruBridge in a report on Thursday, April 10th.
Read Our Latest Research Report on TBRG
Insider Buying and Selling at TruBridge
In other TruBridge news, CEO Christopher L. Fowler sold 6,000 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $25.05, for a total transaction of $150,300.00. Following the transaction, the chief executive officer now directly owns 131,090 shares in the company, valued at approximately $3,283,804.50. This represents a 4.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 10.70% of the company's stock.
TruBridge Trading Down 1.9%
Shares of NASDAQ:TBRG traded down $0.46 during midday trading on Thursday, hitting $23.69. 166,040 shares of the stock were exchanged, compared to its average volume of 128,239. The stock has a market capitalization of $355.89 million, a price-to-earnings ratio of -5.79, a P/E/G ratio of 5.38 and a beta of 0.65. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80. The business's 50-day moving average price is $25.74 and its 200 day moving average price is $23.23. TruBridge, Inc. has a 12 month low of $8.99 and a 12 month high of $32.00.
TruBridge (NASDAQ:TBRG - Get Free Report) last released its earnings results on Friday, May 9th. The company reported $0.29 earnings per share for the quarter, missing analysts' consensus estimates of $0.37 by ($0.08). The firm had revenue of $87.21 million for the quarter, compared to analyst estimates of $86.21 million. TruBridge had a negative net margin of 17.72% and a positive return on equity of 1.78%. Analysts predict that TruBridge, Inc. will post 0.07 earnings per share for the current year.
TruBridge Company Profile
(
Free Report)
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Further Reading
Before you consider TruBridge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.
While TruBridge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
